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Previously reported crystal structures of CFTR F508 del-NBD1 were determined in the presence of solubi-
lizing mutations. In this issue of Chemistry & Biology, Pissarra et al. (2008) show that partial rescue of the
trafficking and gating defects of full-length CFTR occurs in vivo upon recapitulation of the solubilizing
F494N/Q637R or F428S/F494N/Q637R substitutions in cis with F508 del.Cystic fibrosis (CF) disease is caused by
mutations in the 1480-residue cystic fi-
brosis transmembrane conductance reg-
ulator (CFTR) (Riordan et al., 1989).
CFTR is one of a group of over 45 active
transporters termed the ABC transporter
family. Typical family members are orga-
nized into two cytosolic nucleotide-bind-
ing domains and two transmembrane do-
mains. Unique to CFTR is an additional
cytosolic regulatory (R) domainwith phos-
phorylation sites for cAMP-dependent
protein kinase. In healthy individuals,
CFTR localizes to the apical membrane
of epithelial cells, and functions as a chlo-
ride channel. Disease-causing mutations
in the CFTR gene can result in defects in
synthesis, trafficking, stability, function,
and/or regulation of the CFTR protein
(Welsh and Smith, 1993).
The CFTR variant where phenylalanine
508 is deleted (F508 del) is the primary
CF-associated mutation, affecting ap-
proximately two-thirds of alleles (Kerem
et al., 1989). The deletion occurs in the
first N-terminal nucleotide-binding do-
main (NBD1), and causes misfolding and
biosynthetic arrest of CFTR (Amaral,
2006; Lukacs and Durie, 2003). At the
cellular level, F508 del is retained in the
endoplasmic reticulum (ER) by the quality
control (QC) system and is rapidly de-
graded (Yang et al., 1993). Lowering the
incubation temperature of cells express-
ing F508 del CFTR allows the protein to
traffic to the cell surface, suggesting the
defect of F508 del lies in ‘‘kinetic trap(s)’’
in the folding pathway (Cyr, 2005). As
well, the isolated wt NBD1 and F508 del
NBD1 domains do not differ significantly
in terms of thermodynamic stability (Thi-
bodeau et al., 2005), an indication thatother domains of CFTR likely participate
in the overall folding process.
Electron microscopy has provided
overall CFTR topology (Rosenberg et al.,
2004), but atomic resolution data remain
unavailable for the full-length molecule.
Meanwhile, considerable efforts have
been directed toward determining—and
comparing—the structures of normal
versus F508 del forms of NBD1. Initially,
protein appropriate for structural studies
could be obtained only for mouse NBD1
out of 10 organisms tested, including
human (Lewis et al., 2004). Recovery of
human wild-type and F508 del NBD1 for
crystallization ultimately required that cer-
tain amino acid changes be introduced to
the domains in cis (Lewis et al., 2005). The
first human F508 del-NBD1 structure ob-
tained carried seven additional mutations,
three of which (suppressor mutations
G550E, R553Q, and R555K) were known
to rescue the F508 del-CFTR defect
(Chang et al., 1999; DeCarvalho et al.,
2002; Teem et al., 1996). Two F508 del-
NBD1 structures lacking the suppressor
mutations but retaining certain other alter-
ations (F494N/Q637R or F428S/F494N/
Q637R) necessary for protein solubility
subsequently became available (Lewis
et al., 2005, http://www.pdb.org). The lat-
ter structures were found to be nearly
identical to F508 del-NBD1 with the sup-
pressors present (Figure 1A), and all indi-
cated that F508 del promotes little change
in the NBD1 fold overall but does alter lo-
cal surface conformation at the F508 del
site (Figure 1B; Lewis et al., 2004; Lewis,
2005). Small surface changes that impair
interdomain interactions of F508 del-
NBD1, rather than large conformational
changes or an altered fold, were thereforeChemistry & Biology 15, January 20concluded to be the fundamental defect
associated with the F508 del mutation.
In view of this significant number of
background mutations, the question
arises as to whether the solved crystallo-
graphic structure may actually represent
a ‘‘corrected’’ F508 del NBD1. To address
this question, Pissarra et al. (2008) report
in this issue on the trafficking in mamma-
lian cell lines of full-length CFTR proteins
carrying wt, F508 del, or F508 del with
the F494N/Q637R or F429S/F494N/
Q637R replacements. In agreement with
previous studies, wt CFTRwas processed
to themature BandC form, indicating traf-
ficking out of the ER, whereas only a Band
B form was seen for F508 del CFTR, sug-
gesting the protein did not traffic out of
the ER (Amaral, 2006; Lukacs and Durie,
2003). Strikingly, the solubilizing muta-
tions, notably the triple mutant F429S/
F494N/Q637R, appeared to promote
some N-glycan processing in F508 del
CFTR, to produce Band C, along with
bands of MW intermediate between those
of Band B and Band C, suggesting that
these replacements partially rescue the
trafficking defect. Cell surface biotinyla-
tion assays further indicated that proteins
containing the solubilizing mutations were
present at the plasmamembrane. As well,
iodide efflux assays showed that at 37C,
F508 del CFTR containing the solubilizing
mutations had an iodide efflux time course
like that of wt CFTR, albeit with lower
magnitudes that were comparable to
F508 del CFTR rescued by incubation at
26C.At the latter temperature, themagni-
tudes of iodide efflux were similar to wt
CFTR.
Pissarra et al., (2008) also showed that
CFTR molecules carrying solubilizing08 ª2008 Elsevier Ltd All rights reserved 3
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Previewmutations behaved similarly to wt CFTR
with respect to current amplitude, open
probability (Po), mean burst duration
(MBD), and interburst interval (IBI), when
examined at the single channel level by
patch clamp techniques. Whereas F508
del CFTR rescued to the cell surface by
low temperature incubation had a much
different channel gating than wt CFTR,
the presence of the solubilizing mutations
increased the Po, restored the MBD to wt
value, and shortened the prolonged IBI,
particularly the triple mutant which de-
creased the IBI from 10-fold longer than
wt CFTR to only 3-fold.
Given thedegreeof rescuedCFTR func-
tion observed with solubilizing mutations
present, Pissarra et al., (2008) suggest
that available structures of F508 del-
NBD1 represent a partially corrected con-
formation rather than a truly perturbed
NBD1 fold. This may prove to be the
case. However, until a ‘‘naked’’ F508 del-
NBD1 structure becomes available the
specific effects of the solubilizing substitu-
tions on the overall NBD1 fold remain un-4 Chemistry & Biology 15, January 2008 ª20clear, nor do we know whether the ob-
served relatively minor perturbations
(compare wild-type- and F508 del-NBD1
local structure in the 508 region;
Figure 1B) are sufficient to evoke the
structural and functional damage dis-
played by the full-length molecule. Fur-
thermore, it is not known at what stage
chaperones intervene to assist CFTR fold-
ing, nor how well developed are the struc-
tures they sense.
Crystal structures provide a wealth of
atomic detail, yet present rigidified ‘‘snap-
shots’’ of the end-point of protein folding
rather than a motion picture of protein
conformation along its folding pathway
or at its destination structure. At the
same time, trafficking and electrophysio-
logical experiments on full-length CFTR
guide us to conclusions that cannot be
provided by crystallization of a single
domain. As such, a synergistic arsenal
of cell biological and biophysical tech-
niques provides the optimum route to fully
understand the disruptive effects of F508
del.08 Elsevier Ltd All rights reservedREFERENCES
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9484.Figure 1. Solved NBD1 Structures of CFTR
(A) Comparison of F508 del-NBD1 structures. Protein backbone residues are shown as ribbon diagrams.
F508 del-NBD1 structures obtained with solubilizing mutations in cis (F494N/Q637R and F429S/ F494N/
Q637R; Lewis, 2005) are superimposedwith the structure of F508 del-NBD1 obtainedwith solubilizingmu-
tations and suppressor mutants in cis (F409L/F429S/F433L/H667R and G550E/R553Q/R555K, respec-
tively; Lewis et al., 2004). Suppressor mutant side chains are colored pink and solubilizing mutant side
chains colored green where they are visible in the respective crystal structures. Portions of the NBD1
chains corresponding to the regulatory insert (boxed) were invisible in each of the three crystal structures.
The F409L, F429S, and F433L solubilizing substitutions localize to this region of missing density.
(B) Local structure in the F508 region of wild-type (undeleted, blue) and F508 del (gray) NBD1 crystal
structures. The undeleted and F508 del-NBD1 structures carry the solubilizing mutations F429S/
F508A/H667R or F494N/Q637R, respectively. Residues 502–524 of each structure are shown.
Figure produced with Swiss-PdbViewer (Guex and Peitsch, 1997).
